<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Descriptive epidemiology of the <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is always interesting and may reveal time-dependent and geographical variations, as well as occupational exposure </plain></SENT>
<SENT sid="1" pm="."><plain>Epidemiological data in Greece are not available by now </plain></SENT>
<SENT sid="2" pm="."><plain>We have collected and analyzed medical records of <z:hpo ids='HP_0000001'>all</z:hpo> patients with a documented diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, performed by an expert hematologist and/or hematopathologist, in the geographical area of Western Greece, during the 20-year period, defined between 1990 and 2009 </plain></SENT>
<SENT sid="3" pm="."><plain>We have then calculated and described demographic and clinical features of the diagnosed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patient population, and assessed the incidence and prevalence rates of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in Western Greece, during the above-mentioned period </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 855 patients with newly diagnosed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> have been identified </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0005505'>Refractory anemia</z:hpo> was the most common subtype in both FAB and WHO classification systems and in both genders </plain></SENT>
<SENT sid="6" pm="."><plain>Del-5q and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> were more commonly encountered among females, and the dysplastic subtype of <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> among males </plain></SENT>
<SENT sid="7" pm="."><plain><z:mp ids='MP_0004027'>Trisomy</z:mp> 8 was the most common single cytogenetic abnormality </plain></SENT>
<SENT sid="8" pm="."><plain>The crude mean annual incidence rate of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was 6.0 per 100,000 inhabitants aged ≥15 years old (<z:hpo ids='HP_0000001'>all</z:hpo> subtypes according to FAB), and it was 4.8 per 100,000 when <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e> were excluded </plain></SENT>
<SENT sid="9" pm="."><plain>Crude incidence rate was higher in rural than in urban areas, but this finding was not confirmed after age standardization </plain></SENT>
<SENT sid="10" pm="."><plain>Age-standardized mean annual incidence rate in men was 7.9/100,000 and in women 3.4/100,000 </plain></SENT>
<SENT sid="11" pm="."><plain>A continuously increasing incidence rate of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> has been observed throughout the study period </plain></SENT>
</text></document>